Product Info

Table Of Contents
Table H-20. Overall concurrence of YSI (or BGM) values and SG readings using YSI (or BGM) ranges on FST Days 1, 3, and 7; Calibration
3 or 4 times a day, Buttock
YSI
Glucose
Ranges
(mg/dL)
Percent of Matched Pairs-in Each SG Glucose Range for Each YSI Glucose Range
SG (mg/dL)
Number
of
Paired
SG-YSI
<40 ≥40-60 >60-80 >80-120 >120-16
0
>160-20
0
>200-25
0
>250-30
0
>300-35
0
>350-40
0
>400
C) >60-80 12 0.0%
(0/0)
25.0%
(3/12)
33.3%
(4/12)
41.7%
(5/12)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
D)
>80-120
23 0.0%
(0/0)
0.0%
(0/0)
8.7%
(2/23)
73.9%
(17/23)
13.0%
(3/23)
4.3%
(1/23)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
E)
>120-160
36 0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
11.1%
(4/36)
61.1%
(22/36)
27.8%
(10/36)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
F)
>160-200
33 0.0%
(0/0)
0.0%
(0/0)
0.
0%
(0/0)
0.0%
(0/0)
6.1%
(2/33)
72.7%
(24/33)
18.2%
(6/33)
3.0%
(1/33)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
G)
>200-250
27 0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
18.5%
(5/27)
70.4%
(19/27)
11.1%
(3/27)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
H)
>250-300
19 0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
10.5%
(2/19)
78.9%
(15/19)
10.5%
(2/19)
0.0%
(0/0)
0.0%
(0/0)
I)
>300-350
70.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
71.4%
(5/7)
14.3%
(1/7)
14.3%
(1/7)
0.0%
(0/0)
J)
>350-400
------------
Note: For the blank Cells (-), there are no paired points in this reference range.
Table H-21. Overall concurrence of YSI (or BGM) values and SG readings using YSI (or BGM) ranges on FST Day 1; Calibration 3 or 4
times a day, Buttock
YSI
Glucose
Ranges
(mg/dL)
Percent of Matched Pairs-in Each SG Glucose Range for Each YSI Glucose Range
SG (mg/dL)
Number
of
Paired
SG-YSI
<40 ≥40-60 >60-80 >80-120 >120-16
0
>160-20
0
>200-25
0
>250-30
0
>300-35
0
>350-40
0
>400
B) ≥40-60 1 0.0%
(0/0)
100.0%
(1/1)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
C) >60-80 10 0.0%
(0/0)
30.0%
(3/10)
40.0%
(4/10)
30.0%
(3/10)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
D)
>80-120
13 0.0%
(0/0)
0.0%
(0/0)
7.7%
(1/13)
69.2%
(9/13)
15.4%
(2/13)
7.7%
(1/13)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
E)
>120-160
16 0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
6.
3%
(1/16)
50.0%
(8/16)
43.8%
(7/16)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
F)
>160-200
13 0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
69.2%
(9/13)
23.1%
(3/13)
7.7%
(1/13)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
G)
>200-250
70.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
14.3%
(1/7)
71.4%
(5/7)
14.3%
(1/7)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
H)
>250-300
70.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
0.0%
(0/0)
71.4%
(5/7)
28.6%
(2/7)
0.0%
(0/0)
0.0%
(0/0)
388 Chapter 17